logo

CGEN

Compugen·NASDAQ
--
--(--)
--
--(--)
3.33 / 10
Netural

The security demonstrates challenging fundamental health (3.3/10). Positive indicators: Revenue-MV and Profit-MV, but headwinds are noted in Current assets turnover ratio and Gross profit margin (%). Analytical conclusion: defensive.

Fundamental(3.33)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-2.61
Score2/3
Weight22.51%
1M Return11.69%
Inventory turnover ratio
Value47.85
Score3/3
Weight8.67%
1M Return5.26%
Gross profit margin (%)
Value-5.21
Score1/3
Weight-0.76%
1M Return-0.54%
Profit-MV
Value0.46
Score2/3
Weight14.77%
1M Return7.79%
PB-ROE
Value0.35
Score0/3
Weight6.74%
1M Return3.56%
Current assets turnover ratio
Value0.06
Score0/3
Weight-2.70%
1M Return-1.88%
Fixed assets turnover ratio
Value1.54
Score2/3
Weight0.19%
1M Return0.12%
Asset-MV
Value-0.50
Score2/3
Weight33.70%
1M Return15.13%
Cash-MV
Value-0.07
Score2/3
Weight14.79%
1M Return7.73%
Net profit / Total profit (%)
Value100.25
Score2/3
Weight2.09%
1M Return1.28%
Is CGEN undervalued or overvalued?
  • CGEN scores 3.33/10 on fundamentals and holds a Fair valuation at present. Backed by its -43.55% ROE, -400.10% net margin, -8.07 P/E ratio, 3.56 P/B ratio, and -1100.00% earnings growth, these metrics solidify its Netural investment rating.